跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
魏 柏立
教授
,
大腸直腸外科
合聘教授
,
臨床醫學研究所
合聘教授
,
臨床基因體學暨蛋白質體學碩士學位學程
合聘教授
,
細胞治療與再生醫學國際博士學位學程
合聘教授
,
癌症生物學與藥物研發博士學位學程
主治醫師
,
臺北醫學大學附設醫院
成員
,
臺北醫學大學癌症轉譯研究中心
成員
,
臺北醫學大學消化醫學研究中心
https://orcid.org/0000-0002-7275-2661
電子郵件
poliwei
tmu.edu
tw
h-index
4622
引文
37
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
1995 …
2024
每年研究成果
概覽
指紋
網路
專案
(17)
研究成果
(212)
資料集
(9)
類似的個人檔案
(12)
指紋
查看啟用 Po-Li Wei 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Acute Appendicitis
12%
Appendectomy
23%
Bariatric Surgery
10%
Biopsy
10%
Bleeding
8%
Body Mass Index
16%
Breast Cancer
16%
Cancer Cell
19%
Cancer Growth
15%
Cancer Surgery
12%
Carcinogenesis
12%
Carcinoma Cell
10%
Chemoradiotherapy
11%
Colon
11%
Colon Cancer
27%
Colorectal Cancer
57%
Diabetes
8%
Disease
17%
Fluorouracil
10%
Gastric Banding
12%
Gastric Bypass
12%
Gastric Bypass Surgery
12%
Gastroplasty
18%
Glucose Regulated Protein 94
15%
Hepatocellular Carcinoma
20%
In Vitro
11%
Incision
9%
Laparoscopic Surgery
26%
Learning Curve
9%
Malignant Neoplasm
26%
Meta-Analysis
23%
Metastatic Carcinoma
36%
Minimally Invasive Surgery
14%
Morbid Obesity
19%
Neoplasm
42%
Nissen Fundoplication
9%
Open Surgery
9%
Operation Duration
26%
Overall Survival
10%
Quality of Life
16%
Randomized Controlled Trial
37%
Rectum Cancer
51%
Rectum Tumor
11%
Sphincter
11%
Stoma
12%
Surgeon
11%
Surgery
27%
Survival Rate
10%
Systematic Review
17%
Vermiform Appendix
10%
Pharmacology, Toxicology and Pharmaceutical Science
Analgesic Agent
10%
Bevacizumab
15%
Biological Marker
13%
Breast Cancer
27%
Bromelain
7%
Cancer Growth
20%
Carcinogenesis
20%
Catenin
13%
Cetuximab
12%
Chemoradiation Therapy
7%
Chemotherapy
17%
Cisplatin
8%
Colon Cancer
40%
Colorectal Cancer
100%
Combination Therapy
13%
Comorbidity
8%
Curcumin
7%
Cyclooxygenase 2
8%
Disease
18%
Fibronectin
9%
Fluorouracil
12%
Gemcitabine
9%
Glucose Regulated Protein 78
15%
Glucose Regulated Protein 94
11%
Heat Shock Protein 27
11%
Liver Cell Carcinoma
41%
Lymph Node Metastasis
8%
Malignant Neoplasm
65%
Metastasis
17%
microRNA
12%
Morbid Obesity
12%
Mouse
16%
Neoplasm
45%
Nicotine-Derived Nitrosamine Ketone
8%
Nicotinic Receptor
30%
Overall Survival
10%
Oxaliplatin
11%
Paclitaxel
7%
Polyphenol
7%
Randomized Controlled Trial
16%
Reactive Oxygen Metabolite
11%
Rectum Cancer
11%
Recurrent Disease
12%
Small Interfering RNA
9%
Stomach Cancer
15%
Survival Rate
9%
Survivin
15%
Tumor Growth
9%
Tumor Suppressor Protein
9%
Wound Healing
8%
Biochemistry, Genetics and Molecular Biology
Aldehyde Dehydrogenase
7%
Anticancer
7%
Autophagy
12%
Cadherin
8%
Cancer Cell
60%
Cancer Stem Cell
7%
Carcinogenesis
13%
Catenin
17%
Cell Cycle
9%
Cell Growth
10%
Cell Migration
25%
Cell Proliferation
19%
Colon
42%
Cyclooxygenase
8%
down Regulation
12%
Drug Resistance
8%
Eicosanoid Receptor
8%
Electrospinning
5%
Epidermal Growth Factor Receptor
5%
Estrogen Receptor
7%
Fibroblast
5%
Fluorouracil
5%
Gelatinase A
5%
Gene Expression
17%
Gene Mutation
7%
Glucose-Regulated Protein
56%
Heat Shock Protein
15%
Integrin
5%
Mesenchymal-Epithelial Transition
19%
MicroRNA
24%
MMP2
5%
Mouse
5%
MTT Assay
8%
Next Generation Sequencing
5%
Nicotinic Acetylcholine Receptor
10%
Overall Survival
7%
P53
5%
Protein Expression
6%
Real-Time Polymerase Chain Reaction
5%
Signal Transduction
13%
Small Interfering RNA
10%
Survival Rate
5%
Survivin
15%
Thrombomodulin
22%
Tumor Progression
11%
Tumor Suppressor Protein
5%
TUNEL Assay
6%
Upregulation
14%
Vascular Endothelial Growth Factor
8%
Vimentin
7%
